Is the share obtained by Rybelsus indicative of low demand for oral agents in this class, or will novel oral therapies, with improved efficacy, safety, and convenience profiles (e.g
Symptoms may include burning in the chest after eating, pain that worsens when lying down, or a bitter or acidic taste in the mouth
Additionally, the evidence base for efficacy and safety specifically in BED populations remains limited
But on May 22, after reports of side effects, the nations health minister announced the government would ban the production of compounded GLP-1 drugs
In: Diabetes , Band 63, Nummer 7, Juli 2014
Canadian Journal of Soil Science